论文信息 - RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia - 字舞流文

RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia

J. Philippé | Z. Berneman | K. Thielemans | B. Vandekerckhove | G. Leclercq | T. Taghon | T. Kerre | J. Plum | S. Snauwaert | G. Goetgeluk | I. Velghe | S. Vanhee | G. Verstichel | Y. Van Caeneghem | Yasmine Van Caeneghem | Glenn Goetgeluk | Imke Velghe